SPOTLIGHT -
Dr. Nazha on a Mutational Model to Predict Response to Hypomethylating Agents in MDS
Aziz Nazha, MD, discusses a new mutational model to predict response to hypomethylating agents in myelodysplastic syndromes (MDS).
